Tamoxifen synergizes with 4-(E)-{(4-hydroxyphenylimino)-methylbenzene, 1,2-diol} and 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, novel azaresveratrol analogs, in inhibiting the proliferation of breast cancer cells.
about
Tamoxifen synergizes with 4-(E)-{(4-hydroxyphenylimino)-methylbenzene, 1,2-diol} and 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, novel azaresveratrol analogs, in inhibiting the proliferation of breast cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tamoxifen synergizes with 4-(E ...... ration of breast cancer cells.
@en
Tamoxifen synergizes with 4-(E ...... ration of breast cancer cells.
@nl
type
label
Tamoxifen synergizes with 4-(E ...... ration of breast cancer cells.
@en
Tamoxifen synergizes with 4-(E ...... ration of breast cancer cells.
@nl
prefLabel
Tamoxifen synergizes with 4-(E ...... ration of breast cancer cells.
@en
Tamoxifen synergizes with 4-(E ...... ration of breast cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
Tamoxifen synergizes with 4-(E ...... ration of breast cancer cells.
@en
P2093
Amruta Ronghe
Anwesha Chatterjee
Hari K Bhat
Nimee K Bhat
Subhash Padhye
P2860
P304
51747-51762
P356
10.18632/ONCOTARGET.10106
P407
P577
2016-06-16T00:00:00Z